Science 13 January 1989: Vol. 243. no. 4888, pp. 223 - 226 DOI: 10.1126/science.2643161

Prev | Table of Contents | Next

Articles

vFLIP from KSHV inhibits anoikis of primary endothelial cells.

S. Efklidou, R. Bailey, N. Field, M. Noursadeghi, and M. K. Collins (2008)
J. Cell Sci. 121, 450-457
 |  Abstract »  |  Full Text »  |  PDF »

The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1{alpha} in human melanoma cells.

K. Enya, H. Hayashi, T. Takii, N. Ohoka, S. Kanata, T. Okamoto, and K. Onozaki (2008)
J. Leukoc. Biol. 83, 190-199
 |  Abstract »  |  Full Text »  |  PDF »

Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma.

R. F. Little, J. M. Pluda, K. M. Wyvill, I. R. Rodriguez-Chavez, G. Tosato, A. T. Catanzaro, S. M. Steinberg, and R. Yarchoan (2006)
Blood 107, 4650-4657
 |  Abstract »  |  Full Text »  |  PDF »

Associations of Classic Kaposi Sarcoma with Common Variants in Genes that Modulate Host Immunity..

E. E. Brown, D. Fallin, I. Ruczinski, A. Hutchinson, B. Staats, F. Vitale, C. Lauria, D. Serraino, G. Rezza, G. Mbisa, et al. (2006)
Cancer Epidemiol. Biomarkers Prev. 15, 926-934
 |  Abstract »  |  Full Text »  |  PDF »

The Human Herpes Virus 8-Encoded Chemokine Receptor Is Required for Angioproliferation in a Murine Model of Kaposi's Sarcoma.

K. K. Jensen, D. J. Manfra, M. G. Grisotto, A. P. Martin, G. Vassileva, K. Kelley, T. W. Schwartz, and S. A. Lira (2005)
J. Immunol. 174, 3686-3694
 |  Abstract »  |  Full Text »  |  PDF »

Imatinib-Induced Regression of AIDS-Related Kaposi's Sarcoma.

H. B. Koon, G. J. Bubley, L. Pantanowitz, D. Masiello, B. Smith, K. Crosby, J. Proper, W. Weeden, T. E. Miller, P. Chatis, et al. (2005)
J. Clin. Oncol. 23, 982-989
 |  Abstract »  |  Full Text »  |  PDF »

The Kaposin B Protein of KSHV Activates the p38/MK2 Pathway and Stabilizes Cytokine mRNAs.

C. McCormick and D. Ganem (2005)
Science 307, 739-741
 |  Abstract »  |  Full Text »  |  PDF »

Human Herpesvirus 6 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus.

C. Lu, Y. Zeng, Z. Huang, L. Huang, C. Qian, G. Tang, and D. Qin (2005)
Am. J. Pathol. 166, 173-183
 |  Abstract »  |  Full Text »  |  PDF »

Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis.

L. A. Dourmishev, A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac (2003)
Microbiol. Mol. Biol. Rev. 67, 175-212
 |  Abstract »  |  Full Text »  |  PDF »

Antitumorigenic effects of HIV protease inhibitor ritonavir: inhibition of Kaposi sarcoma.

S. Pati, C. B. Pelser, J. Dufraine, J. L. Bryant, M. S. Reitz Jr, and F. F. Weichold (2002)
Blood 99, 3771-3779
 |  Abstract »  |  Full Text »  |  PDF »

Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma.

G. Barillari and B. Ensoli (2002)
Clin. Microbiol. Rev. 15, 310-326
 |  Abstract »  |  Full Text »  |  PDF »

De Novo Infection and Serial Transmission of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Endothelial Cells.

M. Lagunoff, J. Bechtel, E. Venetsanakos, A.-M. Roy, N. Abbey, B. Herndier, M. McMahon, and D. Ganem (2002)
J. Virol. 76, 2440-2448
 |  Abstract »  |  Full Text »  |  PDF »

The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element.

J. An, A. K. Lichtenstein, G. Brent, and M. B. Rettig (2002)
Blood 99, 649-654
 |  Abstract »  |  Full Text »  |  PDF »

Human Herpesvirus-8-Transformed Endothelial Cells Have Functionally Activated Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor.

R. Masood, E. Cesarman, D. L. Smith, P. S. Gill, and O. Flore (2002)
Am. J. Pathol. 160, 23-29
 |  Abstract »  |  Full Text »  |  PDF »

Human Immunodeficiency Virus and Malignancy: Thoughts on Viral Oncogenesis.

W. P. Schecter (2001)
Arch Surg 136, 1419-1425
 |  Full Text »  |  PDF »

Activation of Matrix-Metalloproteinase-2 and Membrane-Type-1-Matrix-Metalloproteinase in Endothelial Cells and Induction of Vascular Permeability In Vivo by Human Immunodeficiency Virus-1 Tat Protein and Basic Fibroblast Growth Factor.

E. Toschi, G. Barillari, C. Sgadari, I. Bacigalupo, A. Cereseto, D. Carlei, C. Palladino, C. Zietz, P. Leone, M. Sturzl, et al. (2001)
Mol. Biol. Cell 12, 2934-2946
 |  Abstract »  |  Full Text »  |  PDF »

Interleukin 8 Is an Autocrine Growth Factor and a Surrogate Marker for Kaposi's Sarcoma.

R. Masood, J. Cai, A. Tulpule, T. Zheng, A. Hamilton, S. Sharma, B. M. Espina, D. L. Smith, and P. S. Gill (2001)
Clin. Cancer Res. 7, 2693-2702
 |  Abstract »  |  Full Text »  |  PDF »

Toward a new generation of vaccines: The anti-cytokine therapeutic vaccines.

D. Zagury, A. Burny, and R. C. Gallo (2001)
PNAS 98, 8024-8029
 |  Abstract »  |  Full Text »  |  PDF »

Kaposi's Sarcoma-Associated Herpesvirus Can Productively Infect Primary Human Keratinocytes and Alter Their Growth Properties.

F. Cerimele, F. Curreli, S. Ely, A. E. Friedman-Kien, E. Cesarman, and O. Flore (2001)
J. Virol. 75, 2435-2443
 |  Abstract »  |  Full Text »  |  PDF »

Endothelin Receptor Blockade Inhibits Proliferation of Kaposi's Sarcoma Cells.

A. Bagnato, L. Rosano, V. Di Castro, A. Albini, D. Salani, M. Varmi, M. R. Nicotra, and P. G. Natali (2001)
Am. J. Pathol. 158, 841-847
 |  Abstract »  |  Full Text »  |  PDF »

CD13/APN is activated by angiogenic signals and is essential for capillary tube formation.

S. V. Bhagwat, J. Lahdenranta, R. Giordano, W. Arap, R. Pasqualini, and L. H. Shapiro (2001)
Blood 97, 652-659
 |  Abstract »  |  Full Text »  |  PDF »

Kaposi sarcoma is a therapeutic target for vitamin D3 receptor agonist.

R. Masood, S. Nagpal, T. Zheng, J. Cai, A. Tulpule, D. L. Smith, and P. S. Gill (2000)
Blood 96, 3188-3194
 |  Abstract »  |  Full Text »  |  PDF »

An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus.

C. B. Foster, T. Lehrnbecher, S. Samuels, S. Stein, F. Mol, J. A. Metcalf, K. Wyvill, S. M. Steinberg, J. Kovacs, A. Blauvelt, et al. (2000)
Blood 96, 2562-2567
 |  Abstract »  |  Full Text »  |  PDF »

Activity of Thalidomide in AIDS-Related Kaposi's Sarcoma.

R. F. Little, K. M. Wyvill, J. M. Pluda, L. Welles, V. Marshall, W. D. Figg, F. M. Newcomb, G. Tosato, E. Feigal, S. M. Steinberg, et al. (2000)
J. Clin. Oncol. 18, 2593-2602
 |  Abstract »  |  Full Text »  |  PDF »

Mechanism of Paclitaxel Activity in Kaposi's Sarcoma.

C. Sgadari, E. Toschi, C. Palladino, G. Barillari, D. Carlei, A. Cereseto, C. Ciccolella, R. Yarchoan, P. Monini, M. Sturzl, et al. (2000)
J. Immunol. 165, 509-517
 |  Abstract »  |  Full Text »  |  PDF »

Induction of HHV-8 Lytic Cycle Replication by Inflammatory Cytokines Produced by HIV-1-Infected T Cells.

M. Mercader, B. Taddeo, J. R. Panella, B. Chandran, B. J. Nickoloff, and K. E. Foreman (2000)
Am. J. Pathol. 156, 1961-1971
 |  Abstract »  |  Full Text »  |  PDF »

Expression of Tie1, Tie2, and Angiopoietins 1, 2, and 4 in Kaposi's Sarcoma and Cutaneous Angiosarcoma.

L. F. Brown, B. J. Dezube, K. Tognazzi, H. F. Dvorak, and G. D. Yancopoulos (2000)
Am. J. Pathol. 156, 2179-2183
 |  Abstract »  |  Full Text »  |  PDF »

Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft.

S. R. Husain and R. K. Puri (2000)
Blood 95, 3506-3513
 |  Abstract »  |  Full Text »  |  PDF »

The Epidemiologic, Pathologic, and Clinical Features of AIDS-Associated Pulmonary Kaposi’s Sarcoma.

D. M. Aboulafia (2000)
Chest 117, 1128-1145
 |  Abstract »  |  Full Text »  |  PDF »

c-Src Mediates Mitogenic Signals and Associates with Cytoskeletal Proteins upon Vascular Endothelial Growth Factor Stimulation in Kaposi's Sarcoma Cells.

N. Munshi, J. E. Groopman, P. S. Gill, and R. K. Ganju (2000)
J. Immunol. 164, 1169-1174
 |  Abstract »  |  Full Text »  |  PDF »

Retrovirally Mediated IFN-{beta} Transduction of Macrophages Induces Resistance to HIV, Correlated with Up-Regulation of RANTES Production and Down-Regulation of C-C Chemokine Receptor-5 Expression.

I. Cremer, V. Vieillard, and E. De Maeyer (2000)
J. Immunol. 164, 1582-1587
 |  Abstract »  |  Full Text »  |  PDF »

Oncostatin M Induces Interleukin-6 and Cyclooxygenase-2 Expression in Human Vascular Smooth Muscle Cells : Synergy With Interleukin-1{beta}.

C. Bernard, R. Merval, M. Lebret, P. Delerive, I. Dusanter-Fourt, S. Lehoux, C. Creminon, B. Staels, J. Maclouf, and A. Tedgui (1999)
Circ. Res. 85, 1124-1131
 |  Abstract »  |  Full Text »  |  PDF »

Human Immunodeficiency Virus Replication in a Primary Effusion Lymphoma Cell Line Stimulates Lytic-Phase Replication of Kaposi's Sarcoma-Associated Herpesvirus.

V. Varthakavi, P. J. Browning, and P. Spearman (1999)
J. Virol. 73, 10329-10338
 |  Abstract »  |  Full Text »  |  PDF »

Kaposi's Sarcoma-associated Herpesvirus-encoded G Protein-coupled Receptor Activation of c-Jun Amino-terminal Kinase/Stress-activated Protein Kinase and Lyn Kinase Is Mediated by Related Adhesion Focal Tyrosine Kinase/Proline-rich Tyrosine Kinase 2.

N. Munshi, R. K. Ganju, S. Avraham, E. A. Mesri, and J. E. Groopman (1999)
J. Biol. Chem. 274, 31863-31867
 |  Abstract »  |  Full Text »  |  PDF »

Perspective on Kaposi's Sarcoma: Facts, Concepts, and Conjectures.

M. S. Reitz Jr., L. S. Nerurkar, and R. C. Gallo (1999)
J Natl Cancer Inst 91, 1453-1458
 |  Full Text »  |  PDF »

Inflammatory Cytokines Synergize with the HIV-1 Tat Protein to Promote Angiogenesis and Kaposi's Sarcoma Via Induction of Basic Fibroblast Growth Factor and the {alpha}v{beta}3 Integrin.

G. Barillari, C. Sgadari, C. Palladino, R. Gendelman, A. Caputo, C. B. Morris, B. C. Nair, P. Markham, A. Nel, M. Sturzl, et al. (1999)
J. Immunol. 163, 1929-1935
 |  Abstract »  |  Full Text »  |  PDF »

Long-Term Infection and Transformation of Dermal Microvascular Endothelial Cells by Human Herpesvirus 8.

A. V. Moses, K. N. Fish, R. Ruhl, P. P. Smith, J. G. Strussenberg, L. Zhu, B. Chandran, and J. A. Nelson (1999)
J. Virol. 73, 6892-6902
 |  Abstract »  |  Full Text »  |  PDF »

The Tat Protein of Human Immunodeficiency Virus Type-1 Promotes Vascular Cell Growth and Locomotion by Engaging the alpha 5beta 1 and alpha vbeta 3 Integrins and by Mobilizing Sequestered Basic Fibroblast Growth Factor.

G. Barillari, C. Sgadari, V. Fiorelli, F. Samaniego, S. Colombini, V. Manzari, A. Modesti, B. C. Nair, A. Cafaro, M. Sturzl, et al. (1999)
Blood 94, 663-672
 |  Abstract »  |  Full Text »  |  PDF »

Identification of the Immediate-Early Transcripts of Kaposi's Sarcoma-Associated Herpesvirus.

F. X. Zhu, T. Cusano, and Y. Yuan (1999)
J. Virol. 73, 5556-5567
 |  Abstract »  |  Full Text »  |  PDF »

Reactivation and Persistence of Human Herpesvirus-8 Infection in B Cells and Monocytes by Th-1 Cytokines Increased in Kaposi's Sarcoma.

P. Monini, S. Colombini, M. Sturzl, D. Goletti, A. Cafaro, C. Sgadari, S. Butto, M. Franco, P. Leone, S. Fais, et al. (1999)
Blood 93, 4044-4058
 |  Abstract »  |  Full Text »  |  PDF »

Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus.

M. Lagunoff, R. Majeti, A. Weiss, and D. Ganem (1999)
PNAS 96, 5704-5709
 |  Abstract »  |  Full Text »  |  PDF »

Sensitization of AIDS-Kaposi's Sarcoma Cells to Apo-2 Ligand-Induced Apoptosis by Actinomycin D.

S. Mori, K. Murakami-Mori, S. Nakamura, A. Ashkenazi, and B. Bonavida (1999)
J. Immunol. 162, 5616-5623
 |  Abstract »  |  Full Text »  |  PDF »

Implication of TNF Receptor-I-Mediated Extracellular Signal-Regulated Kinases 1 and 2 (ERK1/2) Activation in Growth of AIDS-Associated Kaposi's Sarcoma Cells: A Possible Role of a Novel Death Domain Protein MADD in TNF-{alpha}-Induced ERK1/2 Activation in Kaposi's Sarcoma Cells.

K. Murakami-Mori, S. Mori, B. Bonavida, and S. Nakamura (1999)
J. Immunol. 162, 3672-3679
 |  Abstract »  |  Full Text »  |  PDF »

Kinetics of Kaposi's Sarcoma-Associated Herpesvirus Gene Expression.

R. Sun, S.-F. Lin, K. Staskus, L. Gradoville, E. Grogan, A. Haase, and G. Miller (1999)
J. Virol. 73, 2232-2242
 |  Abstract »  |  Full Text »  |  PDF »

Antineoplastic Urinary Protein Inhibits Kaposi's Sarcoma and Angiogenesis In Vitro and In Vivo.

R. Masood, M. E. McGarvey, T. Zheng, J. Cai, N. Arora, D. L. Smith, N. Sloane, and P. S. Gill (1999)
Blood 93, 1038-1044
 |  Abstract »  |  Full Text »  |  PDF »

IFN-{gamma} Induces Endothelial Cells to Proliferate and to Invade the Extracellular Matrix in Response to the HIV-1 Tat Protein: Implications for AIDS-Kaposi's Sarcoma Pathogenesis.

V. Fiorelli, G. Barillari, E. Toschi, C. Sgadari, P. Monini, M. Sturzl, and B. Ensoli (1999)
J. Immunol. 162, 1165-1170
 |  Abstract »  |  Full Text »  |  PDF »

Endogenous Basic Fibroblast Growth Factor Is Essential for Cyclin E-CDK2 Activity in Multiple External Cytokine-Induced Proliferation of AIDS-Associated Kaposi's Sarcoma Cells: Dual Control of AIDS-Associated Kaposi's Sarcoma Cell Growth and Cyclin E-CDK2 Activity by Endogenous and External Signals.

K. Murakami-Mori, S. Mori, and S. Nakamura (1998)
J. Immunol. 161, 1694-1704
 |  Abstract »  |  Full Text »  |  PDF »

FGF-2 stimulates migration of Kaposi's sarcoma-like vascular cells by HGF-dependent relocalization of the urokinase receptor.

U. Cavallaro, Z. Wu, A. D. Palo, R. Montesano, M. S. Pepper, J. A. M. maier, and M. R. Soria (1998)
FASEB J 12, 1027-1034
 |  Abstract »  |  Full Text »

Human Immunodeficiency Virus Tat Modulates the Flk-1/KDR Receptor, Mitogen-Activated Protein Kinases, and Components of Focal Adhesion in Kaposi's Sarcoma Cells.

R. K. Ganju, N. Munshi, B. C. Nair, Z.-Y. Liu, P. Gill, and J. E. Groopman (1998)
J. Virol. 72, 6131-6137
 |  Abstract »  |  Full Text »  |  PDF »

Detection and Titration of Human Herpesvirus-8-Specific Antibodies in Sera From Blood Donors, Acquired Immunodeficiency Syndrome Patients, and Kaposi's Sarcoma Patients Using a Whole Virus Enzyme-Linked Immunosorbent Assay.

L. G. Chatlynne, W. Lapps, M. Handy, Y. Q. Huang, R. Masood, A. S. Hamilton, J. W. Said, H.P. Koeffler, M. H. Kaplan, A. Friedman-Kien, et al. (1998)
Blood 92, 53-58
 |  Abstract »  |  Full Text »  |  PDF »

Identification of Kaposin (Open Reading Frame K12) as a Human Herpesvirus 8 (Kaposi's Sarcoma-Associated Herpesvirus) Transforming Gene.

S. Muralidhar, A. M. Pumfery, M. Hassani, M. R. Sadaie, N. Azumi, M. Kishishita, J. N. Brady, J. Doniger, P. Medveczky, and L. J. Rosenthal (1998)
J. Virol. 72, 4980-4988
 |  Abstract »  |  Full Text »  |  PDF »

Some Aspects of the Pathogenesis of HIV-1-Associated Kaposi's Sarcoma.

R. C. Gallo (1998)
J Natl Cancer Inst Monographs 1998, 55-57
 |  Abstract »  |  Full Text »

Mechanisms of Growth Control of Kaposi's Sarcoma-Associated Herpes Virus-Associated Primary Effusion Lymphoma Cells.

H. Asou, J. W. Said, R. Yang, R. Munker, D. J. Park, N. Kamada, and H. P. Koeffler (1998)
Blood 91, 2475-2481
 |  Abstract »  |  Full Text »  |  PDF »

gamma -Interferon Produced by CD8+ T Cells Infiltrating Kaposi's Sarcoma Induces Spindle Cells With Angiogenic Phenotype and Synergy With Human Immunodeficiency Virus-1 Tat Protein: An Immune Response to Human Herpesvirus-8 Infection?.

V. Fiorelli, R. Gendelman, M. Caterina Sirianni, H.-K. Chang, S. Colombini, P. D. Markham, P. Monini, J. Sonnabend, A. Pintus, R. C. Gallo, et al. (1998)
Blood 91, 956-967
 |  Abstract »  |  Full Text »  |  PDF »

gamma -Interferon Production in Peripheral Blood Mononuclear Cells and Tumor Infiltrating Lymphocytes From Kaposi's Sarcoma Patients: Correlation With the Presence of Human Herpesvirus-8 in Peripheral Blood Mononuclear Cells and Lesional Macrophages.

M. C. Sirianni, L. Vincenzi, V. Fiorelli, S. Topino, E. Scala, S. Uccini, A. Angeloni, A. Faggioni, D. Cerimele, F. Cottoni, et al. (1998)
Blood 91, 968-976
 |  Abstract »  |  Full Text »  |  PDF »

Heterogeneity of Endothelial Cells : Specific Markers.

C. Garlanda and E. Dejana (1997)
Arterioscler Thromb Vasc Biol 17, 1193-1202
 |  Abstract »  |  Full Text »

Glucocorticoids Induce Kaposi's Sarcoma Cell Proliferation Through the Regulation of Transforming Growth Factor-beta.

J. Cai, T. Zheng, M. Lotz, Y. Zhang, R. Masood, and P. Gill (1997)
Blood 89, 1491-1500
 |  Abstract »  |  Full Text »  |  PDF »

Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.

R. Masood, J. Cai, T. Zheng, D. L. Smith, Y. Naidu, and P. S. Gill (1997)
PNAS 94, 979-984
 |  Abstract »  |  Full Text »  |  PDF »

The Effects of Preparations of Human Chorionic Gonadotropin on AIDS-Related Kaposi's Sarcoma.

P. S. Gill, Y. Lunardi-Iskandar, S. Louie, A. Tulpule, T. Zheng, B. M. Espina, J. M. Besnier, P. Hermans, A. M. Levine, J. L. Bryant, et al. (1996)
N. Engl. J. Med. 335, 1261-1267
 |  Abstract »  |  Full Text »  |  PDF »

Kaposi's Sarcoma-Associated Herpesvirus DNA Sequences in Prostate Tissue and Human Semen.

P. Monini, L. de Lellis, M. Fabris, F. Rigolin, and E. Cassai (1996)
N. Engl. J. Med. 334, 1168-1172
 |  Abstract »  |  Full Text »  |  PDF »

Keratinocytes and Cytokine/Growth Factors.

C. Feliciani, A.K. Gupta, and D.N. Saucier (1996)
Critical Reviews in Oral Biology & Medicine 7, 300-318
 |  Abstract »  |  Full Text »  |  PDF »

The HIV-1 TAT Protein Induces the Expression and Extracellular Appearance of Acidic Fibroblast Growth Factor.

S. R. Opalenik, J. T. Shin, J. N. Wehby, V. K. Mahesh, and J. A. Thompson (1995)
J. Biol. Chem. 270, 17457-17467
 |  Abstract »  |  Full Text »  |  PDF »

Mechanisms of Toxicity and Carcinogenesis: July 16-19, 1994, The Gant Conference Center, Aspen, Colorado.

B. F. Trump (1994)
Toxicol Pathol 22, 658-686
 |  PDF »

Risk Factors for Kaposi's Sarcoma in Patients With Advanced Human Immunodeficiency Virus Disease Treated With Zidovudine.

J. E. Gallant, R. D. Moore, D. D. Richman, J. Keruly, and R. E. Chaisson (1994)
Arch Intern Med 154, 566-572
 |  Abstract »  |  PDF »

HIV-Related Tumors of the Oral Cavity.

G. Ficarra and L.E. Eversole (1994)
Critical Reviews in Oral Biology & Medicine 5, 159-185
 |  Abstract »  |  Full Text »  |  PDF »

Kaposi's Sarcoma: Where Do We Go From Here?.

P. L. Myskowski (1993)
Arch Dermatol 129, 1320-1323
 |  Abstract »  |  PDF »

The Immunopathogenesis of Human Immunodeficiency Virus Infection.

G. Pantaleo, C. Graziosi, and A. S. Fauci (1993)
N. Engl. J. Med. 328, 327-335
 |  Full Text »

Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M.

B. Nair, A. DeVico, S Nakamura, T. Copeland, Y Chen, A Patel, T O'Neil, S Oroszlan, R. Gallo, and M. Sarngadharan (1992)
Science 255, 1430-1432
 |  Abstract »  |  PDF »

Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells.

S. Miles, O Martinez-Maza, A Rezai, L Magpantay, T Kishimoto, S Nakamura, S. Radka, and P. Linsley (1992)
Science 255, 1432-1434
 |  Abstract »  |  PDF »

Cyclosporine Inhibits Basic Fibroblast Growth Factor-Driven Proliferation of Human Endothelial Cells and Keratinocytes.

R. J. Sharpe, K. A. Arndt, S. I. Bauer, and T. E. Maione (1989)
Arch Dermatol 125, 1359-1362
 |  Abstract »  |  PDF »

Growth Factors: Their Biology and Promise in Dermatologic Diseases and Tissue Repair.

M. Rothe and V. Falanga (1989)
Arch Dermatol 125, 1390-1398
 |  Abstract »  |  PDF »

Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi's sarcomas.

B. Nickoloff and C. Griffiths (1989)
Science 243, 1736-1737
 |  PDF »

To Advertise   |   Find Products